Published on
June 12, 2025
- 14:00 GMT
Interim report: Nuravax's Alzheimer’s vaccine AV-1959R found safe, immunogenic in all healthy volunteers.
Nuravax’s Alzheimer’s vaccine AV-1959R is safe, triggered strong immune responses in all Phase 1 trial participants, showing promise for disease prevention. IRVINE, CA, UNITED STATES, June 12, 2025 /EINPresswire.com/ -- Nuravax Inc., a biotechnology …
Distribution channels:
Healthcare & Pharmaceuticals Industry
...
